FDA Authorizes Updated COVID-19 Vaccines Targeting Omicron Subvariant

August 31, 2022 by Dan McCue
FDA Authorizes Updated COVID-19 Vaccines Targeting Omicron Subvariant
This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. (Pfizer via AP)

WASHINGTON — The Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots specifically targeting a subvariant of omicron.

The agency approved two options aimed at the BA.5 subvariant of omicron that is now dominant in the U.S.: one made by Pfizer and its German partner BioNTech for use in people as young as 12; the other, manufactured by Moderna, for those 18 and older.

Wednesday’s authorization allows the use of the new bivalent formulations of the vaccines as a single booster dose at least two months following primary or booster vaccination.

 Both represent the first major redesign of the COVID vaccines since they were initially injected into arms in December 2020.


The updated boosters include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component in common between the omicron subvariants BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant. 

The BA.4 and BA.5 lineages of the omicron variant are currently causing most cases of COVID-19 in the U.S. and are predicted to circulate this fall and winter. 

The doses can be given at least two months after people last received a booster dose or completed their initial series of vaccinations.

“As we head into fall and begin to spend more time indoors, we strongly encourage anyone who is eligible to consider receiving a booster dose,” Dr. Robert M. Califf, the F.D.A. commissioner, said in a written statement. 

He added that the newly formulated vaccine would “provide better protection against currently circulating variants.”

But the approval of the new vaccines didn’t come without some push back from members of the FDA advisory committee that reviewed their efficacy.

The concern mainly revolves around the speed at which the new vaccines were turned around — the FDA advised the companies only two months ago on the formulation that they should adopt for the new vaccines — and the resulting lack of human trials.


Both Pfizer and Moderna went to federal regulators this summer with more limited data on the redesigned boosters than a traditional review process would call for — instead of human trials, they presented the outcome of tests of the new vaccines on mice.

Last week, Dr. Paul Offit, a member of the FDA advisory committee, told The Well News he was, at best, skeptical of the data the pharmaceutical companies have presented. 

“As a famous vaccinologist at the Wistar Institute says: ‘Mice lie and monkeys exaggerate,’” he said, referring to the independent, nonprofit research institution in Philadelphia.

“You can’t use mice to predict events in people. You just can’t,” Offit said. “I mean, let me put it this way, if mouse studies were predictive of outcomes in people, we would have had an AIDS vaccine 30 years ago.

“The bottom line is, mice aren’t people. They have a different genome … and while they help sort of point you in the right direction … I just don’t think tests on mice can be used as a proof that something is going to be valuable that you’re about to give to millions of people. I just don’t think that’s adequate. And I think that the American public deserves more data than what we’ve been given,” he said.

But others argue that because the coronavirus is evolving so quickly, human trials would be out of date long before a formal authorization could be handed down.

According to the Centers for Disease Control and Prevention, the number of COVID cases, deaths and hospitalizations are all trending lower.

As of Wednesday morning, the daily average of new cases wass 82,475, with the average daily number of deaths being 387, and the average daily new admissions to hospitals being 5,255.

Vaccinations continue to be at the heart of the Biden administration’s COVID response strategy. 


The White House has already ordered over 170 million doses of the new vaccine for a fall booster campaign, and, now that the FDA has weighed in, expects those boosters to reach the states in a matter of days.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.

A+
a-
  • booster shots
  • COVID-19
  • Food and Drug Administration
  • omicron
  • variants
  • In The News

    Health

    Voting

    Health

    May 31, 2023
    by Dan McCue
    HIV Declines Among Young People, Driving Overall Decrease in New Infections

    ATLANTA — The Centers for Disease Control and Prevention reported this week that estimated annual new HIV infections were 12%... Read More

    ATLANTA — The Centers for Disease Control and Prevention reported this week that estimated annual new HIV infections were 12% lower in 2021 compared to 2017, a drop from about 36,500 infections to about 32,100. According to the CDC, the decline was driven by a 34%... Read More

    May 31, 2023
    by Dan McCue
    FDA Proposes New, Easy-to-Read Medication Guide for Patients

    WASHINGTON — The Food and Drug Administration wants to make it easier for patients to understand why they’ve been prescribed... Read More

    WASHINGTON — The Food and Drug Administration wants to make it easier for patients to understand why they’ve been prescribed specific medications and how to ensure they don’t suffer any preventable adverse reactions when taking them. Toward that end the agency has proposed requiring a new... Read More

    May 31, 2023
    by Dan McCue
    Looking to Lose That Belly Flab? AARP Suggests Comprehensive Approach

    WASHINGTON — The evidence is, well, almost everywhere you turn. According to the National Institutes of Health, more than 50%... Read More

    WASHINGTON — The evidence is, well, almost everywhere you turn. According to the National Institutes of Health, more than 50% of American adults are struggling with belly fat. And the problem becomes more acute as we age. That’s because belly fat, also known as visceral fat,... Read More

    May 31, 2023
    by Dan McCue
    Study Suggests Afternoon Exercise Benefits Those With Type 2 Diabetes

    BOSTON — People who have type 2 diabetes should set aside time to exercise in the afternoon rather than the... Read More

    BOSTON — People who have type 2 diabetes should set aside time to exercise in the afternoon rather than the morning to better manage their blood sugar, according to a study published in Diabetes Care, a journal of the American Diabetes Association. Doctors have long known... Read More

    May 31, 2023
    by Dan McCue
    CDC Finds Sick Workers at Root of Illness Outbreaks Tied to Restaurants

    ATLANTA — If you're sick and work in the restaurant industry, stay home. That’s at least one underlying takeaway from... Read More

    ATLANTA — If you're sick and work in the restaurant industry, stay home. That’s at least one underlying takeaway from a new Centers for Disease Control and Prevention report that found roughly 40% of foodborne illness outbreaks between 2017 and 2019 were at least partly associated... Read More

    May 31, 2023
    by Dan McCue
    VA Relaxes Masking Rules at Health Care Facilities

    WASHINGTON — The Department of Veterans Affairs announced Tuesday that it is relaxing face mask requirements at all of its... Read More

    WASHINGTON — The Department of Veterans Affairs announced Tuesday that it is relaxing face mask requirements at all of its medical facilities. Beginning Tuesday, face masks were no longer required in most clinical areas of these facilities. “Now that the [COVID] public health emergency has ended,... Read More

    News From The Well
    scroll top